Table 2 Unadjusted means (SDs) on all 7,749 PAADRN participants at baseline, 12- and 52-weeks using intention-to-treat (ITT)
| Â | Baseline | 12-weeks | 52-weeks | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Intervention | Control | P-value | Intervention | Control | P-value | Intervention | Control | P-value |
OP care satisfaction (5-25) | 18.9 (2.7)a | 19.1 (2.8)a | 0.011 | 21.1 (3.2) | 20.1 (4.0) | <0.001 | 21.1 (3.2) | 20.5 (3.8) | <0.001 |
Quality of life | |||||||||
 SF-1 (15/30/80/90/95; poor to excellent) | 75.2 (23.8) | 75.1 (24.1) | 0.925 | 74.6 (24.2) | 74.8 (24.4) | 0.746 | 74.5 (24.1) | 75.4 (23.8) | 0.132 |
 EuroQol EQ5D-3 L utility score (0-1) | 0.8 (0.2) | 0.8 (0.2) | 0.676 | 0.8 (0.2) | 0.8 (0.2) | 0.547 | 0.8 (0.2) | 0.8 (0.2) | 0.72 |
 EuroQol visual analog scale of Euroqol (0-100) | 78.1 (16.7) | 78.3 (16.7) | 0.590 | 77.5 (17.6) | 78.2 (17.2) | 0.083 | 77.7 (17.6) | 78.2 (17.1) | 0.244 |
 OPc knowledge – scale score (0-10) | 7.5 (1.9) | 7.5 (1.8) | 0.712 | 7.8 (1.6) | 7.8 (1.6) | 0.759 | 7.8 (1.6) | 7.8 (1.6) | 0.476 |
 Biological risk factors | 2.3 (0.9) | 2.3 (0.9) | 0.345 | 2.5 (0.8) | 2.4 (0.8) | 0.495 | 2.5 (0.8) | 2.5 (0.8) | 0.724 |
 Lifestyle risk factors | 1.8 (0.4) | 1.8 (0.4) | 0.807 | 1.9 (0.3) | 1.9 (0.4) | 0.089 | 1.9 (0.4) | 1.9 (0.4) | 0.327 |
 Consequences | 1.7 (0.6) | 1.7 (0.6) | 0.688 | 1.7 (0.5) | 1.7 (0.5) | 0.471 | 1.7 (0.5) | 1.7 (0.5) | 0.485 |
 Prevention and treatment | 1 (0.8) | 1 (0.8) | 0.974 | 1 (0.8) | 1 (0.8) | 0.726 | 0.9 (0.8) | 0.9 (0.8) | 0.832 |